Skip to main content
5x1000 banner

TERAPIA CRISPCAS9

PER LE SARCOGLICANOPATIE

C.A.R.E. LGMD PROGRAM

| Terapia CrisprCas9

C’è uno studio in corso per la LGMD2i e la LGMD2G negli Stati Uniti.
https://thespeakfoundation.com/c-a-r-e-program?fbclid=IwAR12xyRwqj82REvpPlvAPeE_sl0wRKbzZxwIBPfRIzSK5ENjX3Omo3vsCsg